RNA interference, the process in which small interfering RNAs (SiRNAs) silence a specific gene and thus inhibit the associated protein, has opened new doors for the treatment of a wide range of diseases. However, efficient delivery of SiRNAs remains a challenge, especially due to their instability in biological environments and their inability to cross cell membranes. To protect and deliver SiRNAs to mammalian cells, a variety of polymeric nanocarriers have been developed. Among them, the polysaccharide chitosan has generated great interests. This derivative of natural chitin is biodegradable and biocompatible, and can complex SiRNAs into nanoparticles on account of its positive charges. However, chitosan presents some limitations that need...
The first tool in gene therapy is DNA internalization for genetic deficiencies, and another tool is ...
Chitosan-based nanoparticles have been widely used as a carrier for gene delivery due to their low t...
Purpose: In order to improve siRNA delivery for possible clinical applications, we developed biodegr...
The use of the biomaterial chitosan (CS) to form CS/siRNA nanoparticles for gene silencing have been...
peer reviewedThis study aims at developing chitosan-based nanoparticles suitable for an intravenous ...
The ability to specifically silence genes by RNA interference has an enormous potential for treating...
Gene therapy is an emerging and promising strategy in cancer therapy where small interfering RNA (si...
Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for treatment ...
The mechanism of RNA silencing has first been evidenced in plants. Then, studies on the nematode Cae...
SUMMARY: Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for t...
Gene therapy is promising for the treatment of many currently incurable diseases by delivering or si...
Gene therapy is a new alternative treatment method that involves the internalization of deoxyribonuc...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
A diverse range of viral and non-viral strategies has been developed more than a decade for a gene d...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...
The first tool in gene therapy is DNA internalization for genetic deficiencies, and another tool is ...
Chitosan-based nanoparticles have been widely used as a carrier for gene delivery due to their low t...
Purpose: In order to improve siRNA delivery for possible clinical applications, we developed biodegr...
The use of the biomaterial chitosan (CS) to form CS/siRNA nanoparticles for gene silencing have been...
peer reviewedThis study aims at developing chitosan-based nanoparticles suitable for an intravenous ...
The ability to specifically silence genes by RNA interference has an enormous potential for treating...
Gene therapy is an emerging and promising strategy in cancer therapy where small interfering RNA (si...
Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for treatment ...
The mechanism of RNA silencing has first been evidenced in plants. Then, studies on the nematode Cae...
SUMMARY: Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for t...
Gene therapy is promising for the treatment of many currently incurable diseases by delivering or si...
Gene therapy is a new alternative treatment method that involves the internalization of deoxyribonuc...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
A diverse range of viral and non-viral strategies has been developed more than a decade for a gene d...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...
The first tool in gene therapy is DNA internalization for genetic deficiencies, and another tool is ...
Chitosan-based nanoparticles have been widely used as a carrier for gene delivery due to their low t...
Purpose: In order to improve siRNA delivery for possible clinical applications, we developed biodegr...